The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $189.97

Today's change+2.68 +1.43%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $189.97

Today's change+2.68 +1.43%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Illumina Inc up (U.S.)$2.68

Illumina Inc closed up Friday by (U.S.)$2.68 or 1.43% to (U.S.)$189.97. Over the last five days, shares have gained 3.08% and are currently 3.75% off of the 52-week high. Shares have outperformed the S&P 500 by 69.10% during the last year.

Key company metrics

  • Open(U.S.) $187.80
  • Previous close(U.S.) $187.29
  • High(U.S.) $190.40
  • Low(U.S.) $184.67
  • Bid / Ask-- / --
  • YTD % change+71.78%
  • Volume1,471,849
  • Average volume (10-day)1,091,955
  • Average volume (1-month)1,023,735
  • Average volume (3-month)1,191,687
  • 52-week range(U.S.) $102.30 to (U.S.) $197.37
  • Beta0.74
  • Trailing P/E99.71×
  • P/E 1 year forward71.87×
  • Forward PEG2.82×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.91
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.17%

Based on its net profit margin of 16.17%, Illumina Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014Dec 29, 201312/29/2013
Revenue481448421387
Total other revenue--------
Total revenue481448421387
Gross profit334301278259
Total cost of revenue147147142128
Total operating expense361347329314
Selling / general / administrative120115107106
Research & development85827777
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10323
Other operating expenses, total0000
Operating income1191009274
Interest income (expense), net non-operating-11-10-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax1126084120
Income after tax93476081
Income tax, total19142440
Net income93476081
Total adjustments to net income--------
Net income before extra. items93476081
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items93476081
Inc. avail. to common incl. extra. items93476081
Diluted net income93476081
Dilution adjustment----0--
Diluted weighted average shares148149151144
Diluted EPS excluding extraordinary itemsvalue per share0.630.310.400.56
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.690.330.410.57